A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Phase 1
230
about 5.6 years
18+
17 sites in CA, CO, CT +7
What this study is about
Researchers are testing a treatment called NST-628 for adults with solid tumors that have not responded to other treatments. The trial will evaluate how safe and effective this treatment is.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take NST-628
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Part B: Evaluate objective tumor response rate
Secondary: Part A and B: Characterize the pharmacokinetics of NST-628, Part A and B: Evaluate overall survival (OS), Part A and B: Evaluate progression free survival (PFS), Part A: Evaluate objective tumor response rate
Oncology